Similar articles

• Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.

  Schneider VS, Skurk C, Riedel M, Abdelwahed YS, Landmesser U, Leistner DM. Schneider VS, et al. Clin Res Cardiol. 2017 Jul;106(7):557-559. doi: 10.1007/s00392-017-1091-4. Epub 2017 Apr 3. Clin Res Cardiol. 2017. PMID: 28374059 No abstract available.
• Bioresorbable vascular scaffolds in coronary bifurcation lesions: The next frontiers?

  Leesar MA. Leesar MA. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):870-871. doi: 10.1002/ccd.26850. Catheter Cardiovasc Interv. 2016. PMID: 27886452 No abstract available.
• Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.

  Indolfi C, Mongiardo A, Spaccarotella C, Caiazzo G, Torella D, De Rosa S. Indolfi C, et al. Circ Cardiovasc Imaging. 2014 Jul;7(4):755-7. doi: 10.1161/CIRCIMAGING.114.001727. Circ Cardiovasc Imaging. 2014. PMID: 25027457 No abstract available.
• Bioresorbable vascular scaffolds: implication of very late scaffold thrombosis.

  Mori H, Virmani R, Finn AV. Mori H, et al. Coron Artery Dis. 2017 Nov;28(7):533-538. doi: 10.1097/MCA.0000000000000518. Coron Artery Dis. 2017. PMID: 28692483 Review. No abstract available.
• Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.

  Gogas BD, Garcia-Garcia HM, Onuma Y, Muramatsu T, Farooq V, Bourantas CV, Serruys PW. Gogas BD, et al. JACC Cardiovasc Interv. 2013 Mar;6(3):211-21. doi: 10.1016/j.jcin.2013.01.132. JACC Cardiovasc Interv. 2013. PMID: 23517830 Review.